HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by NewEdge Advisors LLC

NewEdge Advisors LLC lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 47.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,450 shares of the company's stock after selling 3,123 shares during the period. NewEdge Advisors LLC's holdings in HCA Healthcare were worth $1,036,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Whipplewood Advisors LLC bought a new stake in HCA Healthcare in the 4th quarter worth approximately $31,000. Tidemark LLC bought a new stake in HCA Healthcare in the 4th quarter worth approximately $36,000. Activest Wealth Management boosted its stake in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after acquiring an additional 125 shares during the last quarter. Pinnacle Bancorp Inc. boosted its stake in shares of HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after acquiring an additional 50 shares during the last quarter. Finally, Legacy Investment Solutions LLC boosted its stake in shares of HCA Healthcare by 99.0% during the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after acquiring an additional 95 shares during the last quarter. Institutional investors own 62.73% of the company's stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Barclays dropped their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research note on Monday, January 27th. Bank of America lowered their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research note on Monday, January 27th. Robert W. Baird restated a "neutral" rating and set a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Baird R W cut shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Finally, Cantor Fitzgerald restated an "overweight" rating and set a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, HCA Healthcare has an average rating of "Moderate Buy" and a consensus price target of $381.13.

HCA Healthcare Trading Up 1.4 %

Shares of HCA Healthcare stock traded up $4.80 on Wednesday, reaching $345.38. The company had a trading volume of 1,330,377 shares, compared to its average volume of 1,397,627. The firm has a market cap of $85.03 billion, a price-to-earnings ratio of 15.72, a P/E/G ratio of 1.10 and a beta of 1.48. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The firm's 50-day moving average price is $331.02 and its two-hundred day moving average price is $331.49. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The firm had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. During the same quarter in the previous year, the business earned $5.36 EPS. The company's quarterly revenue was up 5.7% on a year-over-year basis. As a group, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.83%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.81%.

Insider Activity

In related news, SVP Jennifer Berres sold 9,533 shares of the business's stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.30% of the company's stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.